Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.93%||69.07||1.0%||$465.79m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.13%||618.11||2.7%||$392.67m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.10%||230.84||1.9%||$334.35m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.00%||2.88||0.7%||$201.32m|
|EXAS||EXACT Sciences Corp.||-1.67%||76.13||17.9%||$160.64m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.51%||91.51||13.7%||$138.71m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.41%||138.62||8.2%||$131.51m|
|BBIO||BridgeBio Pharma, Inc.||-0.51%||11.70||0.0%||$104.26m|
Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA.